↓
 

ParagraphFour.com

Pharmaceutical Patent Database

ParagraphFour.com
  • Home
  • About
  • Paragraph IV Explained
  • FAQ & Terms
  • The PIV Blog
  • PIV Data
    • Get Access
Home→Non-PIV Patent Cases and Non-PIV Inter Partes Reviews

Non-PIV Patent Cases and Non-PIV Inter Partes Reviews

Home › Forums › Non-PIV Patent Cases and Non-PIV Inter Partes Reviews

  • This forum has 1 topic, and was last updated 16 years, 11 months ago by brick.
Viewing topic 1 (of 1 total)
    • Topic
    • Voices
    • Posts
    • Last Post
    • The Non-PIV Cases and IPR’s

      Started by: brick

    • 1
    • 1
    • 16 years, 11 months ago

      brick

  •  

Viewing topic 1 (of 1 total)
  • You must be logged in to create new topics.
Log In

Latest updates

The Paragraph Four Report®
Paragraph IV Activity for October 2020

New Certifications as reported by FDA on October 20, 2020

1. Epinephrine Injection 1mg/mL on 8/13/2020

Comments: Epinephrine has appeared on the PIV List and in PIV cases in the past. This particular filing appears to be the first ANDA filed.

New Cases Filed

1.…[Read more]

Profile picture of parryashford 3 weeks, 3 days ago

Xiidra®(lifitegrast) Ophthalmic Solution
Annual Sales $192M
Company NOVARTIS
Date of First Filing July 13, 2020

Paragraph IV Applicant: Aurobindo
Case Name: NOVARTIS PHARMACEUTICALS CORPORATION v. AUROBINDO PHARMA LTD et al
Court/Case #: Delaware District Court (dedc) 1:2020cv01426
Date Filed: 10/23/20
Judge: Stark
Product…[Read more]

Profile picture of parryashford 3 weeks, 6 days ago

Qbrexza®(glycopyrronium) Topical Cloth
Annual Sales
Company DERMIRA (ELI LILLY)
Date of First Filing January 13, 2020

Paragraph IV Applicant: Perrigo
Case Name: DERMIRA INC et al v. PERRIGO PHARMA INTERNATIONAL DAC
Court/Case #: Delaware District Court (dedc) 1:2020cv01413
Date Filed: 10/21/20
Judge:
Product Strength:…[Read more]

Profile picture of parryashford 1 month ago
The Paragraph Four Report®, ParagraphFour.com® and the PFOUR logo are registered trademarks of Parry Ashford Inc. • ©Parry Ashford Inc. 2020
↑